David R. Blake
24Patents
11h-index
51Co-inventors
78Inventor score
Filing activity: May 1, 1978 → Jan 31, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4239591A | Manufacture of an non-laminated paper web having regions of increased thickness | Textiles; Paper | 62 | Expired |
| US6062739A | Fiber optic connector | Physics | 52 | Expired |
| US8439565B2 | Remotely-aligned arcuate detector array for high energy X-ray imaging | Physics | 39 | Active |
| US6682732B1 | Treatment of lesions | Chemistry; Metallurgy | 33 | Expired |
| US8690427B2 | Methods for high energy X-ray imaging using remotely-aligned arcuate detector array | Physics | 30 | Active |
| US8971487B2 | Stowable arcuate detector array | Physics | 29 | Active |
| US4397867A | Treatment of arthritic complaints | Human Necessities | 28 | Expired |
| US5294630A | Treatment of inflammatory bowel disease | Human Necessities | 18 | Expired |
| US5003098A | Method of reducing or eliminating adverse effects of a pharmaceutical composition or a drug | Chemistry; Metallurgy | 14 | Expired |
| US9282819B2 | Portable animal training table interlockable with like tables | Human Necessities | 14 | Active |
| US5436258A | Prevention of bone resorption | Human Necessities | 12 | Expired |
| US4197706A | Foot-operated hydraulic power source for emergency hydraulic tools | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6220901A | Electric motor terminal board assembly | Electricity | 6 | Expired |
| US5336248A | Treatment and inhibition of retinopathy of prematurity | Human Necessities | 4 | Expired |
| US7902361B2 | Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy | Chemistry; Metallurgy | 4 | Active |
| US5674887A | Prevention of bone resorption | Human Necessities | 3 | Expired |
| US6812834B2 | Reference sample for generating smoky atmosphere | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5714143A | Use of manganese superoxide dismutase (MN-SOD) for preparing pharmaceutical compositions for low-dose treatment of diseases | Human Necessities | 2 | Expired |
| USD985216S1 | Dog balance platform | General | 1 | Active |
| USD986517S1 | Dog balance platform | General | 1 | Active |
| USD985217S1 | Dog balance platform | General | 0 | Active |
| US7829555B1 | Drug targeting | Human Necessities | 0 | Expired |
| US12082556B2 | Dog balance platform | Human Necessities | 0 | Active |
| US9872874B2 | Dosage regimen for sapacitabine and seliciclib | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.